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Simian immunodeficiency virus (SIV) infection is found in a number of African primate species and is
thought to be generally non-pathogenic. However, studies of wild primates are limited to two species,
with SIV infection appearing to have a considerably different outcome in each. Further examination of
SIV-infected primates exposed to their natural environment is therefore warranted. We performed a
large cross-sectional study of a cohort of semi-wild mandrills with naturally occurring SIV infection,
including 39 SIV-negative and 33 species-specific SIVmnd-1-infected animals. This study was
distinguished from previous reports by considerably greater sample size, examination of exclusively
naturally infected animals in semi-wild conditions and consideration of simian T-lymphotropic virus
(STLV) status in addition to SIVmnd-1 infection. We found that SIVmnd-1 infection was associated
with a significant and progressive loss of memory CD4+ T-cells. Limited but significant increases in
markers of immune activation in the T-cell populations, significant increases in plasma neopterin and
changes to B-cell subsets were also observed in SIV-infected animals. However, no increase in
plasma soluble CD14 was observed. Histological examination of peripheral lymph nodes suggested
that SIVmnd-1 infection was not associated with a significant disruption of the lymph node
architecture. Whilst this species has evolved numerous strategies to resist the development of AIDS,
significant effects of SIV infection could be observed when examined in a natural environment.
STLVmnd-1 infection also had significant effects on some markers relevant to understanding SIV
infection and thus should be considered in studies of SIV infection of African primates where present.
INTRODUCTION
Over 40 different African primate species are naturally
infected with a species-specific simian immunodeficiency
virus (SIV). Studies into the outcome of infection are
limited to a few species, with SIV infection of African green
monkeys (Chlorocebus spp.) and sooty mangabeys
(Cercocebus atys) studied extensively, in addition to more
limited examination of SIV infection of mandrills
(Mandrillus sphinx). Such studies have demonstrated the
apparent convergent evolution of multiple mechanisms to
prevent the development of SIV-induced disease in these
‘natural hosts’ of SIV, despite high levels of viral replication
throughout the chronic phase of infection (recently
reviewed by Chahroudi et al., 2012).
Features common to all three of these species include an
extremely low prevalence of CD4+ cells bearing CCR5 (the
principle co-receptor for SIV) (Paiardini et al., 2011;
Two supplementary figures are available with the online version of this
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Pandrea et al., 2007a), a large population of T-cells that are
CD4–, but may be able to carry out functions borne
normally by CD4+ cells (Beaumier et al., 2009; Milush et al.,
2011; Murayama et al., 1999; Vinton et al., 2011), limited
vertical transmission of SIV and suppression of immune
activation after the acute stage of infection (Bosinger et al.,
2009; Kornfeld et al., 2005; Onanga et al., 2002). In African
green monkeys and sooty mangabeys, it has also been
demonstrated that the gut mucosal barrier remains intact in
SIV-infected animals (Gordon et al., 2007; Pandrea et al.,
2007b). These mechanisms appear to be highly successful, as
AIDS-like clinical signs are observed extremely rarely in the
captive populations studied (Pandrea et al., 2001, 2009). It
therefore appears that in the hundreds of thousands (Ma
et al., 2013), if not millions (Gifford et al., 2008) of years of
virus–host co-evolution, a nearly perfect virus–host equi-
librium has been achieved, where high levels of viral
replication can occur without ill effects to the host.
However, the importance of studying such virus–host
interactions in the wild has been indicated by study of
SIVcpz-infected wild chimpanzees (Keele et al., 2009).
When studied in the wild, SIVcpz-infected animals had a
greater risk of mortality, with evidence of CD4+ T-cell
depletion, immune activation and the development of an
AIDS-like disease in one animal (Keele et al., 2009). By
contrast, the few naturally infected chimpanzees housed in
centres in the USA and Europe seemed to suffer no ill
effects of infection (Gilden et al., 1986; Weiss & Heeney,
2009). As a result, SIVcpz infection of chimpanzees was
erroneously thought to be non-pathogenic for over a
decade. A clear picture of the true effect of SIV infection
therefore requires study in the natural environment.
Significant work has been published recently that helps
close this gap in our knowledge. Ma et al. (2013) found
that wild SIV-infected African green monkeys do not show
evidence of chronic immune activation (by measurement
of plasma cytokines) nor do they have increased soluble
CD14 (sCD14), a marker upregulated where the gut
mucosal barrier is compromised. However, due to the
nature of their sampling of wild animals, certain analyses
were not possible in this study, including characterization
of lymphocyte subsets and expression of immune markers
on these cells – fundamental aspects of our understanding
of human immunodeficiency virus type 1 (HIV-1)
infection of humans. In addition, it was not possible to
observe longitudinal effects of SIV infection.
In 1983, a colony of mandrills was established at the
International Centre for Medical Research, Franceville,
Gabon (Wickings, 1995). This colony is maintained in a
large (105 m2) area of dense, natural rainforest and
currently includes .200 mandrills. At least one animal
introduced into this colony was infected with species-
specific SIVmnd-1, which has spread within the colony. An
analysis of the history of the spread of SIV within this
colony and the likely mechanisms for this spread has been
published recently (Fouchet et al., 2012).
This colony provides long-term monitoring possibilities,
with the possibility to capture animals for veterinary
examination and sampling. It provides an ideal situation to
address the outcome of SIV infection of a primate species
in their natural environment. It also provides a valuable
opportunity to study the outcome of natural SIV infection,
avoiding the potential artefacts raised by abnormal routes
of infection or challenge material. We therefore investi-
gated a large cross-section of uninfected and naturally
SIVmnd-1-infected animals to investigate the effect of
natural SIVmnd-1 infection on this apparently well-
adapted host, when studied in an environment represen-
tative of that found in the wild.
RESULTS
Study cohort and viral loads
The study cohort is described in Table 1. The dynamics of
SIVmnd-1 and simian T-lymphotropic virus (STLV)
infection in this cohort prevented precise age- and
gender-matching of the groups. Age and gender were
therefore included as covariates in all statistical tests
throughout this work. Experimentally infected animals
and SIVmnd-2-infected animals were excluded from study
(and SIV therefore refers to SIVmnd-1 throughout). In
addition, only chronically infected animals were included,
by the criterion of known seroconversion at a prior date.
The most recently infected animals were found to have
seroconverted ~6 months prior to this study, while the
longest duration of SIV infection was 14.9 years. One SIV-
positive animal excluded from the study due to testing SIV-
seronegative at the last sampling date was noted to have a
high viral load and unusually high levels of immune
activation, suggestive of acute infection. As it has recently
been suggested that high levels of acute-phase immune
activation in SIV-infected African primates may be an
artefact of experimental infection (Ma et al., 2013), data for
this animal are presented in Fig. S1 (available in JGV
Online). Analysis of plasma SIV viral loads indicated that
STLV co-infection did not have a significant impact on SIV
viral load (P50.7), nor did time since first SIV seroconver-
sion (P50.3) or age (P50.8) in a general linear model.
Interestingly, gender was a significant predictor of viral
load (Fig. 1a), with apparently much higher levels of viral
replication in females.
Noting that our study (including all immunological
analyses described below) was carried out at in late
September and the beginning of October, which corres-
ponds to the end of the peak mandrill breeding season
(July to September) (Setchell et al., 2005), we considered
that hormonal changes in females might lead to minor
immunosuppression and greater viral replication. We
therefore identified animals that had been sampled in the
last 2 years outside of the breeding period (i.e. January–
May) and determined the viral load for these samples. Viral
load was significantly lower in females when sampled
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outside the breeding period; no such relationship between
breeding season and viral load was found in males (Fig. 1b).
SIVmnd-1 infection is associated with a
progressive loss of CD4+ memory T-cells
Absolute numbers of peripheral blood T-cells were deter-
mined by flow cytometry, with no significant differences
found in amounts of CD4+, CD8+, double-negative (DN)
or cd T-cells due to SIV or STLV infection (Fig. 2a). As
found previously for mandrills and other primate species
(Apetrei et al., 2011; Taaffe et al., 2010), there was an inverse
correlation between age and absolute CD3+CD4+ count
(Fig. 2b). However, there was also a significant inverse cor-
relation between the absolute number of CD4+ T-cells and
the time since the animal first tested positive for SIV (Fig.
2c) in a linear model that included age as a covariate. Whilst
it could be argued that age and duration of infection are not
independent (as older animals are likely to be infected for
longer), such a correlation between CD4+ T-cell count was
not found with duration of STLV infection (Fig. 2c), despite
the fact that duration of STLV infection was a far better
correlate with age of the animal than duration of SIV
infection (Fig. 2d).
There was no positive correlation between duration of SIV
infection and the absolute DN T-cell count (Fig. 3a), a
positive correlation between absolute number of CD4+
and DN T-cells in SIV-infected animals (Fig. 3b), and no
significant inverse correlation between the percentage that
these cell types represent of the total lymphocyte
population (Fig. 3c). These findings indicate that the loss
of CD4+ T-cells in SIV-infected animals was not due to
down-modulation of the CD4 molecule by CD4+ T-cells.
Further examination of the naı¨ve and memory T-cell
populations within CD4+ T-cells, defined by CD28 and
CD95 expression, revealed that SIV-infected animals had
significantly fewer memory CD4+ T-cells (Fig. 4a). Memory
T-cells were defined as the sum of the CD28+CD95+ and
(infrequent) CD28–CD95+ populations. As expected, there
was a significant inverse relationship between the number of
Table 1. Demographics of the semi-wild mandrill study cohort: age, gender makeup and (where relevant) SIVmnd-1 plasma viral
loads and duration of SIVmnd-1 infection
Group n Age (years) Gender
(% male)
SIVmnd-1 viral load
(log copies ml”1)
Duration of SIV
infection (years)
Minimum Mean Maximum n Minimum Mean Maximum Minimum Mean Maximum
Uninfected 31 5.0 10.2 23.6 32.3
STLV only 8 7.5 12.1 22.5 37.5
SIVmnd-1
only
11 7.5 9.5 12.7 54.5 7 5.01 5.98 6.53 0.44 4.53 8.5
SIVmnd-1
+STLV
22 8.6 14.0 20.7 68.2 18 4.57 5.87 6.75 1.57 4.86 14.87
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Fig. 1. SIVmnd-1 plasma viral loads. (a) Comparison between the
viral loads of males (n516) and females (n59) within this study
cohort. *Gender was a significant predictor variable in a linear
model of viral load including age and STLV status as covariables,
with P,0.05. (b) Comparison of viral loads between those
measured during this study (‘On’ breeding season) and those
measured in the last 2 years outside the breeding season (‘Off’
breeding season) in males (n511) and females (n55). *P,0.05 in
a two-tailed paired t-test.
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naı¨ve CD4+ T-cells and age, whilst there was no relationship
between age and the number of memory CD4+ T-cells (Fig.
4b). Despite this, the number of memory CD4+ T-cells was
significantly inversely proportional to duration of SIV
infection, suggesting that SIVmnd-1 caused the progressive
loss of these cells (Fig. 4c).
Analysis of T-cell activation markers
In order to determine whether SIVmnd-1 infection was
associated with significant T-cell activation, flow cytometric
analysis was carried out to assess the level of activation
markers on CD4+, CD8+ or DN T-cells (Fig. 5a–c,
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Fig. 2. T-cell subsets in the mandrill cohort. (a) Absolute count of peripheral blood T-cells of the CD4+, CD8+, DN and cd T-
cell populations in uninfected (Neg.), SIVmnd-1-infected (SIV+), STLVmnd-1-infected (STLV+) and SIV/STLV-co-infected
animals (Dual). (b) Age was associated negatively with absolute CD4+ T-cell count in a linear model including gender, SIV and
STLV infection as additional covariates. (c) Within the SIVmnd-1-positive population, duration of SIVmnd-1 infection was
significantly correlated inversely with absolute CD4+ T-cell number in a linear model that included age, gender and STLV
infection status. No such correlation was found with duration of STLV infection in a linear model that included age, gender and
SIV status. (d, e) Duration of SIV infection showed a positive correlation with age that did not reach significance (d), whilst
duration of STLV infection was correlated strongly with age (e), in a linear regression analysis of duration of infection and age
only. Animal numbers: Neg., n528; SIV+, n511; STLV+, n58, Dual, n521; except cd T-cell measurements: Neg., n527;
SIV+, n510.
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analysed. Animal numbers (see Fig. 2 for abbreviations): Neg., n528; SIV+, n510; STLV+; n57; Dual, n520.
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respectively). We found a small but significant increase in
the percentage of CD8+ T-cells expressing Ki-67 in
SIVmnd-1-infected animals, with a trend for SIV to also
induce increased replication of DN T-cells (P50.066).
Diverse effects were seen in the expression of other
markers of T-cell activation, with contradictory effects of
SIV and STLV seen in some cases. STLV infection has
already been demonstrated to cause upregulation of MHC
class II (MHC-II) on CD4+ T-cells (Souquie`re et al.,
2009). We repeated this finding, also observing increased
MHC-II expression in the CD8+ and DN population.
However, we found that in the CD4+ population, SIV
infection was associated with significantly fewer MHC-II+
CD4+ and DN T-cells.
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Fig. 5. Markers of T-cell activation in SIVmnd-1 and STLVmnd-1 infection. (a–c) Percentages of CD4+ (a), CD8+ (b) and DN
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SIV infection was also correlated with fewer CD25+CD4+
and DN T-cells. In humans, a large population of memory
CD4+ T-cells expresses CD25 constitutively (Triplett et al.,
2012), and thus the lower expression of CD25 on CD4+
cells may reflect the loss of memory CD4+ T-cells
described above. Highly significant loss of CCR5+CD4+
lymphocytes was also seen, as has been observed previously
in sooty mangabeys (Veazey et al., 2003). Finally, SIV
infection induced significantly higher levels of the early
activation marker CD69 on both CD4+ and DN T-cells.
Soluble markers of immune activation and gut
integrity
In order to investigate immune activation beyond that found
in T-cells, ELISAs were used to measure the plasma
concentration of soluble markers released by macrophages
in response to different stimuli in a subset of the cohort. A
strong and significant increase in neopterin (released
specifically by macrophages in response to IFN-c) in SIV-
infected animals was found, with a smaller, but also
significant increase in STLV-infected animals (Fig. 6a).
Curiously, neopterin levels were reduced significantly in
SIV-infected animals where STLV was also present. The
amount of plasma neopterin found was correlated positively
with viral load in SIV-infected animals, suggesting that the
increase in neopterin identified was driven by SIV replication
(Fig. 6b). In contrast, sCD14, produced by macrophages in
response to lipopolysaccharide, was not found in greater
concentrations in the SIVmnd-1-infected animals (Fig. 6c)
Identification and quantification of B-cell subsets
and NK cells
Pathogenic HIV-1 infection of humans and SIV infection
of rhesus macaques are associated with disruption of B-cell
populations, but have not yet been analysed in non-
pathogenic SIV infections. We quantified total, naı¨ve and
memory B-cell populations as described previously for
humans and rhesus macaques (Titanji et al., 2010), using a
combination of CD20, CD21 and CD27 (Fig. 7a).
Percentages of the four subsets in the SIV- and STLV-
negative animals are displayed together in Fig. 7(b) to
indicate the normal makeup of the B-cell population.
When the entire study cohort was analysed, there was a
trend approaching significance for SIV-infected animals to
have a higher absolute number of total B-cells (P50.06)
(Fig. 7c) and for STLV-infected animals to have a lower
number (P50.052). Within the B-cell subsets defined here,
the CD21+CD27– population (identified as naı¨ve B-cells in
other species) was not altered in size by SIV or STLV
infection (Fig. 7d). Consistent with this population
representing naı¨ve cells in this species, there was a
significant inverse relationship between number of these
cells and age (P50.02, not shown). SIV infection had no
effect on the quantity of CD21+CD27– or CD21+CD27+
cells. However, SIV infection was associated with a
significant expansion of both CD21– populations.
Surprisingly, these alterations to the B-cell population
were reduced significantly in STLV-infected animals
compared with animals infected with SIVmnd-1 only.
In addition, NK cells were defined and analysed for the first
time in mandrills. NK cells were defined as CD3–CD20–
NKp46+. These cells homogeneously expressed CD8, with
variable CD16 expression. We found no significant changes
in absolute NK cell number, or expression of CD16 related
to SIV or STLV infection, although there was a trend for
increased CD16 expression on NK cells in STLV-infected
animals that approached significance (P50.059) (Fig. S2).
Histological analysis of peripheral lymph nodes
In order to establish the effect of SIV infection on the
architecture of secondary lymphoid tissues, histological
examination of peripheral inguinal lymph nodes from
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uninfected (n57), SIVmnd-1-infected (n511), STLV-
infected (n55) and dual-infected animals (n56) was
carried out. Animals in all groups exhibited a high
frequency of reactive lesions, including basic patterns
(follicular, paracortical, sinusoidal) or mixed patterns with
varied severity, with no apparent trend depending on
retroviral infection status. Unusual collagen deposition was
noted only in a single SIVmnd-1/STLV-co-infected animal,
with mild deposition in the zones surrounding the high
endothelial venules and the reticulin network of fibres in
the subcapsular sinuses.
DISCUSSION
We demonstrate here that natural SIVmnd-1 infection of
mandrills, studied in an environment representative of the
wild, is associated with loss of memory CD4+ T-cells,
increased levels of some markers of T-cell activation,
increased plasma neopterin and perturbations to the B-cell
population.
This is not the first examination of SIV infection in the
International Centre for Medical Research colony. Most
recently, Apetrei et al. (2011) investigated a smaller number
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Fig. 7. SIVmnd-1 infection was associated with significant changes in B-cell populations. (a) B-cells were defined as CD20+
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of mandrills. They studied SIVmnd-1-infected, SIVmnd-2-
infected and dual-infected animals, finding no significant
difference in any marker analysed between uninfected and
SIVmnd-1-infected animals. However, their group size for
SIVmnd-1 infection (n58) was considerably smaller than ours,
a possible explanation as to why they found no differences in
analyses shared between their study and ours, such as the
frequency of Ki-67+ CD8+ T-cells. In addition, our
investigation into immune activation is broader, with a
number of significant differences found in markers not
included in their study. Few naturally SIVmnd-1-infected
animals were included in their study (n54), whilst we
examined exclusively naturally infected animals and animals
housed exclusively in the semi-wild enclosure. The STLV status
of animals in each group of their study was also not reported.
Finally, given the high viral loads found in females in our study,
which we suspect was due to immunosuppressive effects of
reproductive hormones, it is possible that effects of SIVmnd-1
infection were more muted in Apetrei et al. (2011), assuming it
was carried out at a different time of year.
We recognize that this is not the first report of progressive loss
of CD4+ T-cells in natural SIV infection of an African primate
species. Taaffe et al. (2010) reported that over a 5-year period,
SIV-infected sooty mangabeys at the Yerkes National Primate
Research Center (USA) displayed CD4+ loss over time that is
significantly greater than the loss seen in uninfected animals.
However, the authors find a significant correlation between age
and CD4+ T-cell loss, note that the SIV-infected group is
significantly older, but then do not state if the apparent faster
loss of CD4+ T-cells in SIV-infected animals would retain
significance if age was considered as a covariate – indeed, they
propose that the difference in age might explain the observed
phenomenon. In addition, they were unable to show a loss of
either naı¨ve or memory CD4+ T-cells beyond the expected
changes over time also seen in the uninfected population. By
contrast, the trend we have identified in semi-wild mandrills,
for loss of CD4+ over duration of infection, was significant in a
model that included age as a covariate. In addition, we were
able to show that memory CD4+ T-cells specifically are lost in
SIVmnd-1-infected animals.
We identified a pattern of small but significant increases in
chronic T-cell activation induced by SIV and to a lesser
extent STLV. SIV-infected mandrills had an up to 2.2-fold
increase in Ki-67 expression in CD8+ T-cells compared
with uninfected animals. This is therefore below the
increase in these cells of two- to fourfold in chronically
HIV-1-infected humans (Sachsenberg et al., 1998) and the
two- to fourfold increase observed in chronically SIVmac-
infected rhesus macaques (Kaur et al., 2000). In the CD4+
T-cell compartment, we observed significantly higher
expression of the early activation marker CD69, but
significantly fewer MHC-II+ cells. It is tempting to
speculate that this was due to CD4+ T-cells being removed
by SIV infection after the early stages of activation.
Neopterin, one of the first markers of immune activation
to be identified as elevated in HIV-1 infection of humans
and a predictor of disease progression (Fuchs et al., 1989;
Lambin et al., 1986), has thus far (to our knowledge) been
neglected as a marker of interest in studies of the key
models of SIV infection of ‘natural host’ species. It is
therefore unclear at this point whether the significant and
substantial increase in neopterin identified here was found
only due to the semi-wild study environment or whether it
is also a feature of the well-established models of SIV
infection of African primates in captive animals. Notably,
whilst the T-cell activation associated with SIV infections
described here was muted compared with that found in
HIV-1-infected humans, the increases in neopterin
induced by species-specific SIVmnd-1 and STLVmnd-1
reported here were of a similar magnitude to the increases
demonstrated in HIV-1- and human T-lymphotropic virus
type 1 (HTLV-1)-infected humans (Ali et al., 1992; Lambin
et al., 1986). Neopterin is produced by macrophages in
response to IFN-c, the source of which remains uniden-
tified in this model.
Alterations to the B-cell subsets have not been reported
previously in African primate species. The changes demon-
strated here must be interpreted with caution, as rigorous
determination of the functions of the B-cell subsets defined
by CD21 and CD27 was not within the scope of this study.
However, it is tempting to draw parallels between the
phenomena observed here and the accumulation of CD21–
‘exhausted’ cells observed in HIV-1 infection of humans
(Moir et al., 2008). Further work is therefore required to
characterize the nature of these changes.
Whilst we see no significant disruption of the lymph node
architecture in SIVmnd-1-infected animals, reactive patterns
were found frequently in all animals, further suggesting that
animals in this population have a high exposure to other
infectious agents, mirroring the situation in truly wild
primates. The finding of mild collagen deposition in only a
single animal suggests that this type of disruption of lymph
node architecture, found in both HIV-1-infected humans
(Schacker et al., 2002) and in wild chimpanzees (Keele et al.,
2009), is not present in this model.
The findings of our study also differ somewhat from
recently published findings on wild African green monkeys,
in which no evidence of immune activation was found (Ma
et al., 2013). However, we note that in the one analysis
shared between the two studies, our finding is the same – a
lack of increased plasma sCD14. It therefore appears that in
both species, even in the wild, where the mucosal barrier is
presumably under greater stress from other pathogens able
to disrupt it, SIV infection does not cause the catastrophic
loss of integrity of this barrier found in pathogenic
infections. The limited immune activation found in this
study of mandrills must therefore have another cause. Our
study also raises some points for consideration for the
ongoing work examining African green monkeys in their
natural environment (e.g. consideration of breeding season
in the analysis of viral load, the effects of STLV co-
infection, and the utility of determining plasma neopterin
SIVmnd-1 infection of semi-wild mandrills
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concentration as a sensitive and relevant measure of
immune activation in retroviral infection).
Of note to future studies, we demonstrate here that several
markers relevant to understanding the outcome of SIV
infection were also affected significantly by STLV-1
infection. This includes markers of interest that were
upregulated by STLV and, surprisingly, some analyses
where STLV co-infection appears to ameliorate the
phenotype induced by SIV. We note that STLV co-
infection does not appear to be considered in the key
studies of wild primates (Keele et al., 2009; Ma et al., 2013)
nor is STLV status reported in the many studies of the
outcome of SIV infection of sooty mangabeys at the Yerkes
National Primate Research Centre (Silvestri et al., 2003;
Sumpter et al., 2007; Taaffe et al., 2010), despite the high
prevalence of STLV-1 in this colony (Traina-Dorge et al.,
2005). We suggest that identifying the effect of STLV
infection may be useful in future attempts to measure the
consequences of SIV infection. Whilst many key para-
meters measured here were not affected by STLV-1
infection (e.g. only two markers of T-cell activation were
affected), it would be inappropriate to predict the effect of
STLV infection on such markers in other species based on
these results. In addition, the study of SIV infection of
sooty mangabeys includes multiple analyses that are
beyond the scope of this investigation into mandrills, for
which no data on the effect of STLV infection exists in any
species.
As a final consideration, we note that in addition to
multiple mechanisms for preventing the development of
AIDS, African green monkeys, sooty mangabeys and
mandrills have also developed strong barriers to vertical
transmission of SIV infection, which appears to be rare in
these species (Chahroudi et al., 2012; Pandrea et al., 2008).
It is unclear as to why there should have been selection
towards this phenotype if SIV infection is not detrimental.
We also note that whilst rare, AIDS-like cases have been
described for all three of these species (Pandrea et al.,
2009), in animals infected for a long period of time. In
mandrills, the only case of an AIDS-like syndrome
associated with SIVmnd-1 infection was described in an
animal held in the semi-wild enclosure aged ~20 years old
and SIV-infected for at least 17 years (Pandrea et al., 2001).
Given that previous reports have found no effect of chronic
SIVmnd-1 infection on CD4+ count or immune activation
(Apetrei et al., 2011; Pandrea et al., 2003), it is unclear if
the development of AIDS in this case was due to the
protracted length of SIV infection or instead due to some
specific susceptibility of this animal to disease. In this
study, we find that SIVmnd-1 infection of mandrills held in
the semi-wild enclosure is associated generally with
significant loss of memory CD4+ T-cells, moderate
increases in activation of both T-cells and macrophages
(indicated by plasma neopterin), and for the first time in a
‘natural host’ species, changes in the makeup of the B-cell
population. We propose that these observations lend
weight to a theory that SIVmnd-1 infection has a general
potential to cause disease in mandrills exposed to their
natural environment, given sufficient duration of infection,
but the slow rate of damage to the immune system,
combined with the paucity of vertical transmission,
prevents the development of disease in most animals.
METHODS
Ethics statement. This study was carried out in strict accordance
with European Directive CEE 10/63. The protocol was approved by
the Committee on the Ethics of Animal Experiments of the
Department of Veterinary Medicine, University of Cambridge
(permit no. CR54). Blood draws and excision of inguinal lymph
nodes were carried out under ketamine/HCl [10 mg (kg body
weight)21] anaesthesia. All efforts were made to minimize animal
suffering.
Animals. Animals included in the study were adult or late
adolescents, .5 years old for females and .7.5 years for males (on
average mandrills reach adult body mass at age 5 years in females and
age 8 years in males; Wickings & Dixson, 1992).
Serological screening. Plasma was tested for the presence of SIV
antibodies with an in-house strain-specific ELISA-based assay using
SIVmnd-1 lineage-specific V3-loop as antibody capture antigens
(Simon et al., 2001). STLV-1 was confirmed as described previously
(Souquie`re et al., 2009). Briefly, plasma was screened for cross-reactive
antibodies to HTLV-I/II by ELISA (HTLV-I Platelia New, Bio-Rad or
Vironostica, bioMe´rieux). STLV-1 infection was confirmed by Western
blotting (HTLV blot 2.4; Diagnostic Biotechnology) or InnoLIA
HTLV-I/II strip assay (Innogenetics).
SIVmnd-1 viral load. Viral load assays were performed as described
previously (Lie´geois et al., 2012). Briefly, the assay is an integrase-based
real-time PCR assays using a minor groove binder probe specific of
SIVmnd-1. For the quantitative PCR standard, a virus-specific plasmid
was used (Invitrogen). Primers: AGTAAGTGCTGTCATCATGGAGA;
GTTTCTGCTGTTATAACTTCTGCCTTC. Probe: AGATGCTTCAC-
TTGGAGTC.
Flow cytometric analysis. For staining of surface markers, 100 ml
whole blood was incubated with a mAb mixture in a 5 ml polystyrene
round-bottomed tube (Falcon 2058; BD) at room temperature for
15 min. Antibodies were selected on the basis of cross-reactivity and
were titrated for this species. After this first incubation, 1.5 ml FACS
lysing solution (BD) was added to all tubes, followed by incubation at
room temperature for 15 min and then centrifugation for 5 min at
500 g. The supernatant was aspirated [with the exception of tubes
with counting beads (AccuCheck; Invitrogen), which were directly
acquired], and cells were washed with 1 ml PBS and centrifuged for
5 min at 500 g. This washing step was finished by aspiration of the
majority of the supernatant followed by data collection on a
FACScalibur (BD). Intracellular Ki-67 staining was carried out with
a slight variation on this procedure. After lysis, centrifugation and
removal of supernatant, cells were resuspended in 16 Perm/Wash
solution (BD) containing fluorescently conjugated anti-Ki-67 and
incubated for 30 min at room temperature in the dark before a wash
with 16 Perm/Wash solution and acquisition. Data were analysed
with FlowJo v9 (Tree Star). Compensation was carried out post-
acquisition based on data for single-stained cells acquired in parallel.
Group sizes varied for flow cytometric analysis: pre-acquisition, some
animals were excluded due to limited availability of materials; post-
acquisition, absolute count data were excluded from animals that did
not pass the AccuCheck internal quality control. Antibodies against
the following markers were used, with clone names in parentheses:
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CD3e (SP34.2; BD), CD3cd (B1.1), CD4 (SK3), CD8 (SK1), CD16
(3G8), CD20 (L27; BD), CD21 (B-ly4; BD), CD25 (4e3; Mulitenyi),
CD27 (M-T247; BD), CD28 (CD28.2), CD69 (FN50), CD95 (DX2),
MHC-II (L243), Ki-67 (B56) and CCR5 (3A9; BD). Antibodies were
supplied by Ebioscience, unless specified.
Analysis of plasma soluble markers. Commercial ELISA kits were
used to test for plasma concentration of neopterin and sCD14,
supplied by IBL International and Abcam, respectively. Assays were
carried out according to the manufacturer’s instructions.
Histological analysis of inguinal lymph nodes. Excision lymph
node biopsies were collected in 10 % saline-buffered formalin and
embedded in paraffin. Blocks were cut into 4 mm sections on to
standard glass slides, stained using haematoxylin & eosin and Masson’s
trichrome, and examined by light microscopy. Histological examina-
tion was undertaken without knowledge of infection status.
Statistical analysis. The R package (http://www.r-project.org/) was
used for the majority of the statistical analysis. General linear models
were used to determine if SIV and STLV infection had a significant
effect on the response variable in question. Age, gender, and SIVmnd-
1 and STLV status were included as explanatory variables in all
models, and an interaction between SIV and STLV was included
where this improved model fit. Age, gender and STLV status were also
retained as predictor variables when investigating the effect of
duration of SIV infection or viral load within the SIV-positive group.
Variable data were transformed where necessary to produce
normality. Differences in viral load between the breeding and non-
breeding season were analysed using a paired t-test in Prism 5.0
(GraphPad).
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